Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Mohammad K. A. Basra"'
Autor:
Juliana Catucci Boza, Mohammad K. A. Basra, Rafaela Caminha Vanin, Renata Rosa Carvalho, Magda Blessmann Weber, Tania Ferreira Cestari
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 88, Iss 3, Pp 482-484 (2013)
Psoriasis Family Index is a quality of life instrument for family members of patients with psoriasis developed in English. The aims of this study were to translate the Psoriasis Family Index into Brazilian Portuguese, culturally adapt it and verify i
Externí odkaz:
https://doaj.org/article/091113ad659f44f8abb8253ad196e0c2
Autor:
Masaru Tanaka, Yuko Higaki, Yuko Futei, Mohammad K. A. Basra, Andrew Yule Finlay, Toshiko Kamo
Skin conditions affect the quality of life (QoL) of patients and their family. To assess family members' QoL, a questionnaire uniquely designed for family members is necessary. We translated the Family Dermatology Life Quality Index (FDLQI), original
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ea6d5da56ae4347af590f94a5b60e6e
Autor:
Mohammad K. A. Basra, Hossein Safizadeh, S. Shamsi-meymandi, Nasim Pourdamghan, Nouzar Nakhaee
Publikováno v:
Quality of Life Research. 23:869-875
Family Dermatology Life Quality Index (FDLQI) is an instrument for assessing the quality of life of family members of dermatologic patients. The aim of this study was to describe the cultural adaptation of this questionnaire and to assess psychometri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8fd2b40ae4969cb60d68453b3690848
https://doi.org/10.1007/s11136-013-0514-6
https://doi.org/10.1007/s11136-013-0514-6
Autor:
Sam Salek, E. A. Holm, Matthias Augustin, Mohammad K. A. Basra, Tamar Nijsten, J. de Korte, Cecilia A.C. Prinsen, Francesca Sampogna
Publikováno v:
Journal of the European Academy of Dermatology and Venereology, 27(10), 1195-1203. Wiley-Blackwell
In the last decade, the importance of the measurement of health-related quality of life (HRQoL) has grown significantly. Today, HRQoL measurement is generally considered to be important in clinical trials, in the assessment of disease severity, in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8676058e3d8a496e3529b32f9ad15c72
https://doi.org/10.1111/jdv.12090
https://doi.org/10.1111/jdv.12090
Autor:
Sadath Hussain, Mohammad K. A. Basra
Publikováno v:
Chinese Journal of Integrative Medicine. 18:179-185
The significance of patient-reported outcomes (PROs) is increasingly being acknowledged and quality of life (QOL) has become an integral element of the assessment of overall burden of disease. Psoriasis has been known for its major impact on patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb95403cef47feb68aa422dd3f581cd2
https://doi.org/10.1007/s11655-012-1007-0
https://doi.org/10.1007/s11655-012-1007-0
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 27:109-115
Background The Dermatology Life Quality Index (DLQI) is one of the most frequently used scales to evaluate theimpact of skin disease on patients’ quality of life (QoL). There has not been psychometric evaluation of the Chineseversion of DLQI in Chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e46714ddbd6f6f260955c202255f544
https://doi.org/10.1111/j.1468-3083.2011.04371.x
https://doi.org/10.1111/j.1468-3083.2011.04371.x
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 9:271-283
Skin diseases are among the most common health problems worldwide and are associated with a considerable burden. The burden of skin disease is a multidimensional concept that encompasses psychological, social and financial consequences of the skin di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf78a0d32b57262ca317945f0140bc45
https://doi.org/10.1586/erp.09.23
https://doi.org/10.1586/erp.09.23
Autor:
Elizabeth J. Horn, Peter C.M. van de Kerkhof, Rajesh Balkrishnan, Andrew Yule Finlay, Steven R. Feldman, Mohammad K. A. Basra, Alan Menter, Dan McCoy
Publikováno v:
Journal of the American Academy of Dermatology, 59, 1009-16
Journal of the American Academy of Dermatology, 59, 6, pp. 1009-16
Journal of the American Academy of Dermatology, 59, 6, pp. 1009-16
Contains fulltext : 71313.pdf (Publisher’s version ) (Closed access) Topical therapy has an important role in psoriasis treatment. It is efficacious and has a favorable safety profile as demonstrated in clinical trials. However, poor treatment outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c91f5f51e7b77a0ccdbfcea21e2ee545
https://doi.org/10.1016/j.jaad.2008.08.028
https://doi.org/10.1016/j.jaad.2008.08.028
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 22:813-821
Aim: To adapt the Impact on Family scale (IOF), originally developed for families of children with chronic illnesses, for use in families of adult patients and to examine the convergent validity of the Family Dermatology Life Quality Index (FDLQI) by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8865ea740400c7e7ca08a022f2dd9bea
https://doi.org/10.1111/j.1468-3083.2008.02593.x
https://doi.org/10.1111/j.1468-3083.2008.02593.x
Publikováno v:
British Journal of Dermatology. 156:929-937
BACKGROUND: Although the impact of skin disease on patients' health-related quality of life (HRQoL) is well known, little work has been carried out to determine the secondary impact of a patient's skin disease on the patient's family or partner. OBJE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9435d41ed74c756944c90d8aadc0194b
https://doi.org/10.1111/j.1365-2133.2007.07794.x
https://doi.org/10.1111/j.1365-2133.2007.07794.x